In vivo Raman spectroscopy for tumor border assessment in extramammary Paget disease
Biomedical Optics Express · 2026-12-01 · 17 (12) · 6215
DOI: 10.1364/boe.603447 ↗Abstract
Extramammary Paget disease (EMPD) often has ill-defined clinical borders, and gross inspection may underestimate the true extent of Paget cell involvement. We performed in vivo Raman spectroscopy immediately before tissue sampling in three patients with EMPD. Raman spectra were obtained from the clinically apparent tumor (T), the peritumoral border zone (P), and normal-appearing skin (N). Exploratory spectral differences were observed between the T and N regions. The P-region spectra showed different distributions across the three cases: in the well-demarcated lesion, P largely overlapped with N; in one ill-defined lesion, P ranged from profiles closer to T to those closer to N; and in the other ill-defined lesion, P was positioned closer to T than to N. Representative Raman–histopathology comparisons in Case 1 supported heterogeneous Paget cell involvement within P, although exact point-by-point spatial validation was not feasible. These findings suggest that Raman spectroscopy may help characterize subclinical extension in EMPD.
EUVIMED